middle.news
PainChek Raises A$7.5m to Unlock US Market with FDA Clearance Imminent
10:21am on Monday 28th of July, 2025 AEST
•
Healthcare
Read Story
PainChek Raises A$7.5m to Unlock US Market with FDA Clearance Imminent
10:21am on Monday 28th of July, 2025 AEST
Key Points
A$7.5 million placement at 15% discount to last traded price
US FDA clearance expected by September/October 2025
110,000 net contracted licenses with A$5.4 million annual recurring revenue
Expansion plans include US, Canada, UK, Australia, and New Zealand
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Painchek (ASX:PCK)
OPEN ARTICLE